126 related articles for article (PubMed ID: 29781781)
1. Gene expression microarray analysis reveals prognostic markers of survival in high grade astrocytomas.
Yang J; Hou Z; Wang C; Wang H; Zhang H
Neurol Res; 2018 Sep; 40(9):744-751. PubMed ID: 29781781
[TBL] [Abstract][Full Text] [Related]
2. The Use of Three Long Non-Coding RNAs as Potential Prognostic Indicators of Astrocytoma.
Zhi F; Wang Q; Xue L; Shao N; Wang R; Deng D; Wang S; Xia X; Yang Y
PLoS One; 2015; 10(8):e0135242. PubMed ID: 26252651
[TBL] [Abstract][Full Text] [Related]
3. High CHI3L1 expression is associated with glioma patient survival.
Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
[TBL] [Abstract][Full Text] [Related]
4. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
5. Tumor Grade versus Expression of Invasion-Related Molecules in Astrocytoma.
Virga J; Bognár L; Hortobágyi T; Zahuczky G; Csősz É; Kalló G; Tóth J; Hutóczki G; Reményi-Puskár J; Steiner L; Klekner A
Pathol Oncol Res; 2018 Jan; 24(1):35-43. PubMed ID: 28161812
[TBL] [Abstract][Full Text] [Related]
6. Identification of the interaction network of hub genes for melanoma treated with vemurafenib based on microarray data.
Quan L; Wang Y; Liang J; Shi J; Zhang Y; Tao K
Tumori; 2015; 101(4):368-74. PubMed ID: 25983087
[TBL] [Abstract][Full Text] [Related]
7. Increased immune gene expression and immune cell infiltration in high-grade astrocytoma distinguish long-term from short-term survivors.
Donson AM; Birks DK; Schittone SA; Kleinschmidt-DeMasters BK; Sun DY; Hemenway MF; Handler MH; Waziri AE; Wang M; Foreman NK
J Immunol; 2012 Aug; 189(4):1920-7. PubMed ID: 22802421
[TBL] [Abstract][Full Text] [Related]
8. CDC20 with malignant progression and poor prognosis of astrocytoma revealed by analysis on gene expression.
Ding Y; Yu S; Bao Z; Liu Y; Liang T
J Neurooncol; 2017 May; 133(1):87-95. PubMed ID: 28432586
[TBL] [Abstract][Full Text] [Related]
9. PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status.
Roodakker KR; Elsir T; Edqvist PD; Hägerstrand D; Carlson J; Lysiak M; Henriksson R; Pontén F; Rosell J; Söderkvist P; Stupp R; Tchougounova E; Nistér M; Malmström A; Smits A
Oncotarget; 2016 Nov; 7(45):72431-72442. PubMed ID: 27626492
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-13 receptor alpha 2 as a marker of poorer prognosis in high-grade astrocytomas.
Wanibuchi M; Kataoka-Sasaki Y; Sasaki M; Oka S; Otsuka Y; Yamaguchi M; Ohnishi H; Ohtaki S; Noshiro S; Ookawa S; Mikami T; Mikuni N; Honmou O
J Neurosurg Sci; 2018 Jun; 62(3):239-244. PubMed ID: 28079349
[TBL] [Abstract][Full Text] [Related]
11. Region-Specific Dok2 Overexpression Associates with Poor Prognosis in Human Astrocytoma.
Deshpande RP; Chandra Sekhar YBVK; Panigrahi M; Babu PP
Mol Neurobiol; 2018 Jan; 55(1):402-408. PubMed ID: 27975172
[TBL] [Abstract][Full Text] [Related]
12. Metallothionein Genes are Highly Expressed in Malignant Astrocytomas and Associated with Patient Survival.
Masiulionytė B; Valiulytė I; Tamašauskas A; Skiriutė D
Sci Rep; 2019 Apr; 9(1):5406. PubMed ID: 30932010
[TBL] [Abstract][Full Text] [Related]
13. A 63 signature genes prediction system is effective for glioblastoma prognosis.
Zhang Y; Xu J; Zhu X
Int J Mol Med; 2018 Apr; 41(4):2070-2078. PubMed ID: 29393370
[TBL] [Abstract][Full Text] [Related]
14. Co-expression of mitosis-regulating genes contributes to malignant progression and prognosis in oligodendrogliomas.
Liu Y; Hu H; Zhang C; Wang H; Zhang W; Wang Z; Li M; Zhang W; Zhou D; Jiang T
Oncotarget; 2015 Nov; 6(35):38257-69. PubMed ID: 26468983
[TBL] [Abstract][Full Text] [Related]
15. Identification of glioblastoma gene prognosis modules based on weighted gene co-expression network analysis.
Xu P; Yang J; Liu J; Yang X; Liao J; Yuan F; Xu Y; Liu B; Chen Q
BMC Med Genomics; 2018 Nov; 11(1):96. PubMed ID: 30382873
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of a seven-microRNA classifier as a novel biomarker for the prediction and detection of recurrence in glioma patients.
Chen W; Yu Q; Chen B; Lu X; Li Q
Oncotarget; 2016 Aug; 7(33):53392-53413. PubMed ID: 27438144
[TBL] [Abstract][Full Text] [Related]
17. Expression and prognostic value of NDRG2 in human astrocytomas.
Li L; Wang J; Shen X; Wang L; Li X; Liu Y; Shi M; Zhao G; Deng Y
J Neurol Sci; 2011 Sep; 308(1-2):77-82. PubMed ID: 21705028
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of the EGFR/FKBP12/HIF-2alpha pathway identified in childhood astrocytomas by angiogenesis gene profiling.
Khatua S; Peterson KM; Brown KM; Lawlor C; Santi MR; LaFleur B; Dressman D; Stephan DA; MacDonald TJ
Cancer Res; 2003 Apr; 63(8):1865-70. PubMed ID: 12702575
[TBL] [Abstract][Full Text] [Related]
19. Expression site of P2RY12 in residential microglial cells in astrocytomas correlates with M1 and M2 marker expression and tumor grade.
Zhu C; Kros JM; van der Weiden M; Zheng P; Cheng C; Mustafa DA
Acta Neuropathol Commun; 2017 Jan; 5(1):4. PubMed ID: 28073370
[TBL] [Abstract][Full Text] [Related]
20. A systemic insight into astrocytoma biology across different grades.
Chakraborty S; Ghosh Z
J Cell Physiol; 2019 Apr; 234(4):4243-4255. PubMed ID: 30146735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
